33 results on '"Staal, Ben"'
Search Results
2. Abstract A014: Combinations of previously reported biomarkers achieve improved sensitivity and specificity of detection of early stage pancreatic ductal adenocarcinoma
3. Supplementary Figures S1-S9 from Strengthening Context-Dependent Anticancer Effects on Non–Small Cell Lung Carcinoma by Inhibition of Both MET and EGFR
4. Supplementary Figure Legends from Strengthening Context-Dependent Anticancer Effects on Non–Small Cell Lung Carcinoma by Inhibition of Both MET and EGFR
5. Supplementary Table 2 from Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
6. Supplemental Data from Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
7. Supplementary Data from The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis
8. Supplementary Table 1 from Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
9. Supplementary Table 3 from Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
10. Data from MET Kinase Inhibitor SGX523 Synergizes with Epidermal Growth Factor Receptor Inhibitor Erlotinib in a Hepatocyte Growth Factor–Dependent Fashion to Suppress Carcinoma Growth
11. Supplementary Methods, Figures 1-4 from MET Kinase Inhibitor SGX523 Synergizes with Epidermal Growth Factor Receptor Inhibitor Erlotinib in a Hepatocyte Growth Factor–Dependent Fashion to Suppress Carcinoma Growth
12. Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
13. Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation
14. The Framing Preference for Large and Increasing Components in Static and Dynamic Descriptions
15. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
16. Abstract PR-010: Blinded and meta-analysis validation of an improved serological test for PDAC using the combination of CA19-9 and the sTRA glycan
17. Abstract PO-002: Detection of chemotherapy-resistant pancreatic cancer using a glycan Biomarker
18. Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker
19. Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice
20. MOESM1 of Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
21. Abstract 3147A: The use of the sTRA glycan for predicting responses to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma
22. The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis
23. Mining High-Complexity Motifs in Glycans: A New Language To Uncover the Fine Specificities of Lectins and Glycosidases
24. Abstract LB-015: Differential therapeutic responses of MET oncogenic activations to Met kinase inhibitor and neutralizing antibody
25. Abstract 4624: The sTRA glycan is complementary to CA19-9 as a serologic biomarker of pancreatic cancer
26. Strengthening Context-Dependent Anticancer Effects on Non–Small Cell Lung Carcinoma by Inhibition of Both MET and EGFR
27. Abstract 2167: Strengthening anti-cancer effects on non-small cell lung carcinoma by dual blockage of MET and EGFR in a context-dependent manner.
28. Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation
29. Abstract 4092: Cancer-type regulation of MIG-6 expression by 5-Aza-2′-deoxycytidine and Trichostatin A
30. MET Kinase Inhibitor SGX523 Synergizes with Epidermal Growth Factor Receptor Inhibitor Erlotinib in a Hepatocyte Growth Factor–Dependent Fashion to Suppress Carcinoma Growth
31. Abstract LB-305: Why two are better than one: Suppression of carcinoma cell growth in vitro and in human HGF/SF transgenic SCID by inhibitors of MET (SGX523) and EGFR (erlotinib)
32. Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation.
33. A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.